Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation

被引:21
|
作者
Minami, Yuichiro [1 ]
Haruki, Shintaro [1 ]
Yashiro, Bun [1 ]
Suzuki, Tsuyoshi [1 ]
Ashihara, Kyomi [1 ]
Hagiwara, Nobuhisa [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan
关键词
Atrial fibrillation; Atrium; Hypertrophic cardiomyopathy; Prognosis; NONSUSTAINED VENTRICULAR-TACHYCARDIA; MIDVENTRICULAR OBSTRUCTION; PROGNOSTIC-SIGNIFICANCE; CARDIOVASCULAR EVENTS; SEPTAL REDUCTION; CLINICAL-COURSE; SIZE; ASSOCIATION; POPULATION; REGISTRY;
D O I
10.1016/j.jjcc.2016.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationships among enlarged left atrial dimension (LAD), the presence or absence of atrial fibrillation (AF), and sudden death risk in patients with hypertrophic cardiomyopathy (HCM) remain unclear. The aim of this study was to evaluate the impact of enlarged LAD on sudden death risk in HCM patients with or without documented AF. Methods: This study included 564 HCM patients (follow-up period: 10.8 +/- 7.4 years). LAD was measured from the parasternal long-axis view as the antero-posterior linear diameter at end-systole. Sudden death was defined as the combined endpoint of sudden cardiac death and potentially lethal arrhythmic events, and log rank tests and Cox proportional hazards models were applied to evaluate the impact of LAD enlargement on the combined endpoint. Results: The proportions of patients with sudden death and potentially lethal arrhythmic events were significantly higher among patients with enlarged LAD (>= 48 mm, N = 86) compared with those without enlarged LAD (19.8% vs. 8.2%; p = 0.002). However, enlarged LAD was not identified as an independent determinant of sudden death risk in multivariate analysis of all study HCM patients [adjusted hazard ratio (HR): 1.83; 95% confidence interval (CI): 0.95-3.53; p = 0.071]. Among patients without documented AF during the follow-up periods, enlarged LAD was an independent determinant of sudden death risk (adjusted HR: 5.23; 95% CI: 2.17-12.58; p < 0.001), although there was no significant difference in sudden death risk between patients with and without enlarged LAD in patients with documented AF (adjusted HR: 0.77; 95% CI: 0.31-1.90; p = 0.567). Conclusions: These results suggest that the relationship between LAD and outcome is influenced by the presence or absence of AF in HCM patients. It may thus be necessary to consider the need to prevent sudden death in LAD-enlarged HCM patients without documented AF. (C) 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 50 条
  • [31] Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
    Tian, Hongwei
    Cui, Jingang
    Yang, Chengzhi
    Hu, Fenghuan
    Yuan, Jiansong
    Liu, Shengwen
    Yang, Weixian
    Jiang, Xiaowei
    Qiao, Shubin
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [32] Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
    Hongwei Tian
    Jingang Cui
    Chengzhi Yang
    Fenghuan Hu
    Jiansong Yuan
    Shengwen Liu
    Weixian Yang
    Xiaowei Jiang
    Shubin Qiao
    BMC Cardiovascular Disorders, 18
  • [33] Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study
    Liao, Min-Tsun
    Wu, Cho-Kai
    Juang, Jyh-Ming Jimmy
    Lin, Ting-Tse
    Wu, Chih-Cheng
    Lin, Lian-Yu
    ECLINICALMEDICINE, 2021, 34
  • [34] Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy
    Bhopalwala, Huzefa
    Dewaswala, Nakeya
    Liu, Sijia
    Scott, Christopher G.
    Welper, James M.
    Akinnusotu, Oluwatoyin
    Bos, Johan Martijn
    Ommen, Steve R.
    Ackerman, Michael J.
    Pellikka, Patricia A.
    Geske, Jeffrey B.
    Noseworthy, Peter
    Arruda-Olson, Adelaide M.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2021, 38 (02): : 183 - 188
  • [35] Atrial fibrillation and the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy - a nationwide cohort study using insurance claims database
    Lin, T. T. L.
    Juang, J. J. J.
    Wu, C. K. W.
    Liao, M. T. L.
    Wu, C. C. W.
    Lin, L. Y. L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 209 - 209
  • [36] Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
    Choi, You-Jung
    Kim, Bongseong
    Rhee, Tae-Min
    Lee, Hyun-Jung
    Lee, Heesun
    Park, Jun-Bean
    Lee, Seung-Pyo
    Han, Kyung-Do
    Kim, Yong-Jin
    Kim, Hyung-Kwan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [37] Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
    Choi, Y. J.
    Kim, B. S.
    Rhee, T. M.
    Lee, H. J.
    Lee, H.
    Park, J. B.
    Lee, S. P.
    Han, K. D.
    Kim, Y. J.
    Hk, K. I. M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1734 - 1734
  • [38] Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
    You-Jung Choi
    Bongseong Kim
    Tae-Min Rhee
    Hyun-Jung Lee
    Heesun Lee
    Jun-Bean Park
    Seung-Pyo Lee
    Kyung-Do Han
    Yong-Jin Kim
    Hyung-Kwan Kim
    Scientific Reports, 12
  • [39] Stroke and Embolic Events in Hypertrophic Cardiomyopathy Risk Stratification in Patients Without Atrial Fibrillation
    Haruki, Shintaro
    Minami, Yuichiro
    Hagiwara, Nobuhisa
    STROKE, 2016, 47 (04) : 936 - 942
  • [40] Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation
    Debonnaire, Philippe
    Joyce, Emer
    Hiemstra, Yasmine
    Mertens, Bart J.
    Atsma, Douwe E.
    Schalij, Martin J.
    Bax, Jeroen J.
    Delgado, Victoria
    Marsan, Nina Ajmone
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (02):